Novel identified receptors on mast cells

Frontiers in Immunology

Volumn 3, Issue AUG, 2012, Pages

  Migalovich Sheikhet, Helena ^a   Friedman, Sheli ^a,b   Mankuta, David ^b   Levi Schaffer, Francesca ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Activating receptors; Costimulation cross talk; Function; Inhibitory receptors; Ligands; Mast cells; Signal transduction

Indexed keywords

EID: 84874199748     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2012.00238     Document Type: Article

References (189)

1. Akdis, M., Burgler, S., Crameri, R., Eiwegger, T., Fujita, H., Gomez, E., Klunker, S., Meyer, N., O'Mahony, L., Palomares, O., Rhyner, C., Ouaked, N., Schaffartzik, A., van de Veen, W., Zeller, S., Zimmermann, M., and Akdis, C. A. (2011). Interleukins, from 1 to 37, and interferon-gamma: receptors, functions, and roles in diseases. J. Allergy Clin. Immunol. 127, 701-721 e701-770.
2. Akira, S., and Takeda, K. (2004). Toll-like receptor signalling. Nat. Rev. Immunol. 4, 499-511.
3. Alcon, V. L., Luther, C., Balce, D., and Takei, F. (2009). B-cell co-receptor CD72 is expressed on NK cells and inhibits IFN-gamma production but not cytotoxicity. Eur. J. Immunol. 39, 826-832.
4. Allakhverdi, Z., Comeau, M. R., Jessup, H. K., Yoon, B. R., Brewer, A., Chartier, S., Paquette, N., Ziegler, S. F., Sarfati, M., and Delespesse, G. (2007). Thymic stromal lym-phopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells. J. Exp. Med. 204, 253-258.
5. Altinova, A. E., Yetkin, I., Akbay, E., Bukan, N., and Arslan, M. (2008). Serum IL-18 levels in patients with type 1 diabetes: relations to metabolic control and microvas-cular complications. Cytokine 42, 217-221.
6. Alvarez, Y., Tang, X., Coligan, J. E., and Borrego, F. (2008). The CD300a (IRp60) inhibitory receptor is rapidly up-regulated on human neutrophils in response to inflammatory stimuli and modulates CD32a (FcgammaRIIa) mediated signaling. Mol. Immunol. 45, 253-258.
7. Alvarez-Errico, D., Oliver-Vila, I., Ainsua-Enrich, E., Gilfillan, A. M., Picado, C., Sayos, J., and Martin, M. (2011). CD84 negatively regulates IgE high-affinity receptor signaling in human mast cells. J. Immunol. 187, 5577-5586.
8. Arend, W. P., Palmer, G., and Gabay, C. (2008). IL-1, IL-18, and IL-33 families of cytokines. Immunol. Rev. 223, 20-38.
9. Asadi, S., Alysandratos, K. D., Angeli-dou, A., Miniati, A., Sismanopou-los, N., Vasiadi, M., Zhang, B., Kalogeromitros, D., and Theo-harides, T. C. (2012). Substance P (SP) induces expression of functional corticotropin-releasing hormone receptor-1 (CRHR-1) in human mast cells. J. Invest. Derma-tol. 132, 324-329.
10. Askenase, P. W., Herzog, W. R., Millet, I., Paliwal, V., Ramabhadran, R., Rochester, C., Geba, G. P., and Ptak, W. (1991). Serotonin initiation of delayed-type hypersensi-tivity: mediation by a primitive Thy-1+ antigen-specific clone or by specific monoclonal IgE antibody. Skin Pharmacol. 4(Suppl. 1), 25-42.
11. Aye, C. C., Toda, M., Morohoshi, K., and Ono, S. J. (2012). Identification of genes and proteins specifically regulated by costimulation of mast cell Fcepsilon receptor I and chemokine receptor 1. Exp. Mol. Pathol. 92, 267-274.
12. Bachelet, I., Munitz, A., Berent-Maoz, B., Mankuta, D., and Levi-Schaffer, F. (2008). Suppression of normal and malignant kit signaling by a bispecific antibody linking kit with CD300a. J. Immunol. 180, 6064-6069.
13. Bachelet, I., Munitz, A., Mankutad, D., and Levi-Schaffer, F. (2006). Mast cell costimulation by CD226/CD112 (DNAM-1/Nectin-2): a novel interface in the allergic process. J. Biol. Chem. 281, 27190-27196.
14. Bachelet, I., Munitz, A., Moretta, A., Moretta, L., and Levi-Schaffer, F. (2005). The inhibitory receptor IRp60 (CD300a) is expressed and functional on human mast cells. J. Immunol. 175, 7989-7995.
15. Baslund, B., Tvede, N., Danneskiold-Samsoe, B., Larsson, P., Panayi, G., Petersen, J., Petersen, L. J., Beurskens, F. J., Schuurman, J., van de Winkel, J. G., Parren, P. W., Gracie, J. A., Jongbloed, S., Liew, F. Y., and Mcinnes, I. B. (2005). Targeting interleukin-15 in patients with rheumatoid arthritis: a proof-of-concept study. Arthritis Rheum. 52, 2686-2692.
16. Berger, M., Gray, J. A., and Roth, B. L. (2009). The expanded biology of serotonin. Annu. Rev. Med. 60, 355-366.
17. Bochner, B. S. (2009). Siglec-8 on human eosinophils and mast cells, and Siglec-F on murine eosinophils, are functionally related inhibitory receptors. Clin. Exp. Allergy 39, 317-324.
18. Brightling, C. E., Kaur, D., Berger, P., Morgan, A. J., Wardlaw, A. J., and Bradding, P. (2005). Differential expression of CCR3 and CXCR3 by human lung and bone marrow-derived mast cells: implications for tissue mast cell migration. J. Leukoc. Biol. 77, 759-766.
19. Bruhns, P., Iannascoli, B., England, P., Mancardi, D. A., Fernandez, N., Jorieux, S., and Daeron, M. (2009). Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses. Blood 113, 3716-3725.
20. Buhring, H. J., Streble, A., and Valent, P. (2004). The basophil-specific ectoenzyme E-NPP3 (CD203c) as a marker for cell activation and allergy diagnosis. Int. Arch. Allergy Immunol. 133, 317-329.
21. Bulanova, E., Budagian, V., Orin-ska, Z., Koch-Nolte, F., Haag, F., and Bulfone-Paus, S. (2009). ATP induces P2X7 receptor-independent cytokine and chemokine expression through P2X1 and P2X3 receptors in murine mast cells. J. Leukoc. Biol. 85, 692-702.
22. Bulanova, E., and Bulfone-Paus, S. (2010). P2 receptor-mediated signaling in mast cell biology. Purinergic Signal. 6, 3-17.
23. Burnstock, G. (2007). Purine and pyrimidine receptors. Cell. Mol. Life Sci. 64, 1471-1483.
24. Cantoni, C., Bottino, C., Augugliaro, R., Morelli, L., Marcenaro, E., Castri-coni, R., Vitale, M., Pende, D., Sivori, S., Millo, R., Biassoni, R., Moretta, L., and Moretta, A. (1999). Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human NK cells. Eur. J. Immunol. 29, 3148-3159.
25. Cevikbas, F., and Steinhoff, M. (2012). IL-33: a novel danger signal system in atopic dermatitis. J. Invest. Dermatol. 132, 1326-1329.
26. Clark, G. J., Ju, X., Tate, C., and Hart, D. N. (2009). The CD300 family of molecules are evolutionarily significant regulators of leukocyte functions. Trends Immunol. 30, 209-217.
27. Colucci, E (2007). Unexpected partnership between IL-15 and DAP10. Nat. Immunol.8, 1289-1291.
28. Comas-Casellas, E., Martinez-Barriocanal, A., Miro, F., Ejarque-Ortiz, A., Schwartz, S. Jr., Martin, M., and Sayos, J. (2012). Cloning and characterization of CD300d, a novel member of the human CD300 family of immune receptors. J. Biol. Chem. 287, 9682-9693.
29. Comeau, M. R., and Ziegler, S. E (2010). The influence of TSLP on the allergic response. Mucosal Immunol. 3, 138-147.
30. Corrigan, C. J., Jayaratnam, A., Wang, Y., Liu, Y., de Waal Malefyt, R., Meng, Q., Kay, A. B., Phipps, S., Lee, T. H., and Ying, S. (2009). Early production of thymic stromal lymphopoi-etin precedes infiltration of dendritic cells expressing its receptor in allergen-induced late phase cutaneous responses in atopic subjects. Allergy 64, 1014-1022.
31. Daeron, M., Jaeger, S., Du Pasquier, L., and Vivier, E. (2008).Immunorecep-tor tyrosine-based inhibition motifs: a quest in the past and future. Immunol. Rev. 224, 11-43.
32. Drube, S., Heink, S., Walter, S., Lohn, T., Grusser, M., Gerbaulet, A., Berod, L., Schons, J., Dudeck, A., Freitag, J., Grotha, S., Reich, D., Rudeschko, O., Norgauer, J., Hartmann, K., Roers, A., and Kamradt, T. (2010). The receptor tyrosine kinase c-Kit controls IL-33 receptor signaling in mast cells. Blood 115, 3899-3906.
33. Dunford, P. J., Williams, K. N., Desai, P. J., Karlsson, L., Mcqueen, D., and Thurmond, R. L. (2007). Histamine H4 receptor antagonists are superior to traditional antihistamines in the attenuation of experimental pruritus. J. Allergy Clin. Immunol. 119, 176-183.
34. Edwards, M. J. (2008). Therapy directed against thymic stromal lymphopoi-etin. Drug News Perspect. 21, 312-316.
35. Elishmereni, M., Alenius, H. T., Bradding, P., Mizrahi, S., Shikotra, A., Minai-Fleminger, Y., Mankuta, D., Eliashar, R., Zabucchi, G., and Levi-Schaffer, E (2011). Physical interactions between mast cells and eosinophils: a novel mechanism enhancing eosinophil survival in vitro. Allergy 66, 376-385.
36. Elishmereni, M., and Levi-Schaffer, E (2011). CD48: a co-stimulatory receptor of immunity. Int. J. Biochem. Cell Biol. 43, 25-28.
37. Fang, C., Siew, L. Q., Corrigan, C. J., and Ying, S. (2010). The role of thymic stromal lymphopoi-etin in allergic inflammation and chronic obstructive pulmonary disease. Arch. Immunol. Ther. Exp. (Warsz.) 58, 81-90.
38. Feng, C., Mery, A. G., Beller, E. M., Favot, C., and Boyce, J. A. (2004). Adenine nucleotides inhibit cytokine generation by human mast cells through a Gs-coupled receptor. J. Immunol. 173, 7539-7547.
39. Fifadara, N. H., Beer, F., Ono, S., and Ono, S. J. (2010). Interaction between activated chemokine receptor 1 and FcepsilonRI at membrane rafts promotes communication and F-actin-rich cytoneme extensions between mast cells. Int. Immunol. 22, 113-128.
40. Forsythe, P., and Ennis, M. (1999). Adenosine, mast cells and asthma. Inflamm. Res. 48, 301-307.
41. Francis, H. L., Demorrow, S., Franchitto, A., Venter, J. K., Mancinelli, R. A., White, M. A., Meng, F., Ueno, Y., Carpino, G., Renzi, A., Baker, K. K., Shine, H. E., Francis, T. C., Gau-dio, E., Alpini, G. D., and Onori, P. (2012). Histamine stimulates the proliferation of small and large cholangiocytes by activation of both IP(3)/Ca(2 and cAMP-dependent signaling mechanisms. Lab. Invest. 92, 282-294.
42. Gao, P. S., Shimizu, K., Grant, A. V., Rafaels, N., Zhou, L. F., Hudson, S. A., Konno, S., Zimmer-mann, N., Araujo, M. I., Ponte, E. V., Cruz, A. A., Nishimura, M., Su, S. N., Hizawa, N., Beaty, T. H., Mathias, R. A., Rothenberg, M. E., Barnes, K. C., and Bochner, B. S. (2010). Polymorphisms in the sialic acid-binding immunoglobulin-like lectin-8 (Siglec-8) gene are associated with susceptibility to asthma. Eur. I Hum. Genet. 18, 713-719.
43. Gever, J. R., Cockayne, D. A., Dillon, M. P., Burnstock, G., and Ford, A. P. (2006). Pharmacology of P2X channels. Pflugers Arch. 452, 513-537.
44. Gibbs, B. F., and Levi-Schaffer, E (2012). H4 receptors in mast cells and basophils: a new therapeutic target for allergy? Front. Biosci. 17, 430-437.
45. Godfrey, W R., Fagnoni, E E, Harara, M. A., Buck, D., and Engleman, E. G. (1994). Identification of a human OX-40 ligand, a costimula-tor of CD4+ T cells with homology to tumor necrosis factor. J. Exp. Med. 180, 757-762.
46. Godot, V., Arock, M., Garcia, G., Capel, E, Flys, C., Dy, M., Emilie, D., and Humbert, M. (2007). H4 histamine receptor mediates optimal migration of mast cell precursors to CXCL12. J. Allergy Clin. Immunol. 120, 827-834.
47. Goeders, N. E., and Guerin, G. F. (2000). Effects of the CRH receptor antagonist CP-154, 526 on intravenous cocaine self-administration in rats. Neuropsychopharmacology 23, 577-586.
48. Gordon, J. R., Zhang, X., Stevenson, K., and Cosford, K. (2000). Throm-bin induces IL-6 but not TNFal-pha secretion by mouse mast cells: threshold-level thrombin receptor and very low level FcepsilonRI signaling synergistically enhance IL-6 secretion. Cell. Immunol. 205, 128-135.
49. Gracie, J. A., Forsey, R. J., Chan, W L., Gilmour, A., Leung, B. P., Greer, M. R., Kennedy, K., Carter, R., Wei, X. Q., Xu, D., Field, M., Foulis, A., Liew, E Y, and Mcinnes, I. B. (1999). A proinflammatory role for IL-18 in rheumatoid arthritis. J. Clin. Invest. 104, 1393-1401.
50. Grammatopoulos, D. K. (2011). Insights into mechanisms of corticotropin-releasing hormone receptor signal transduction. Br. J. Pharmacol. 166, 85-97.
51. Gri, G., Piconese, S., Frossi, B., Manfroi, V., Merluzzi, S., Tripodo, C., Viola, A., Odom, S., Rivera, J., Colombo, M. P., and Pucillo, C. E. (2008). CD4+CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction. Immunity 29, 771-781.
52. Harada, M., Obara, K., Hirota, T., Yoshimoto, T., Hitomi, Y., Sakashita, M., Doi, S., Miyatake, A., Fujita, K., Enomoto, T., Taniguchi, M., Higashi, N., Fukutomi, Y., Nakanishi, K., Nakamura, Y., and Tamari, M. (2009). A functional polymorphism in IL-18 is associated with severity of bronchial asthma. Am. J. Respir. Crit. Care Med. 180, 1048-1055.
53. Hauswirth, A. W., Escribano, L., Pra-dos, A., Nunez, R., Mirkina, I., Kneidinger, M., Florian, S., Son-neck, K., Vales, A., Schernthaner, G. H., Sanchez-Munoz, L., Sperr, W R., Buhring, H. J., Orfao, A., and Valent, P. (2008). CD203c is overexpressed on neoplastic mast cells in systemic mastocytosis and is upregulated upon IgE receptor cross-linking. Int. J. Immunopathol. Pharmacol. 21, 797-806.
54. He, R., and Geha, R. S. (2010). Thymic stromal lymphopoietin. Ann. N Y. Acad. Sci. 1183, 13-24.
55. Helmby, H., and Grencis, R. K. (2002). IL-18 regulates intestinal mastocytosis and Th2 cytokine production independently of IFN-gamma during Trichinella spiralis infection. J. Immunol. 169, 2553-2560.
56. Hofstra, C. L., Desai, P. J., Thurmond, R. L., and Fung-Leung, W P. (2003). Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells. J. Pharmacol. Exp. Ther. 305, 1212-1221.
57. Homey, B., and Bunemann, E. (2004). Chemokines and inflammatory skin diseases. Ernst Schering Res. Found. Workshop 45, 69-83.
58. Homey, B., Meller, S., Savinko, T., Alenius, H., and Lauerma, A. (2007). Modulation of chemokines by staphylococcal superantigen in atopic dermatitis. Chem. Immunol. Allergy 93, 181-194.
59. Homey, B., Steinhoff, M., Ruzicka, T., and Leung, D. Y (2006). Cytokines and chemokines orchestrate atopic skin inflammation. J. Allergy Clin. Immunol. 118, 178-189.
60. Howlett, A. C. (2005). Cannabinoid receptor signaling. Handb. Exp. Pharmacol. 168, 53-79.
61. Hsu, C. L., Neilsen, C. V., and Bryce, P. J. (2010). IL-33 is produced by mast cells and regulates IgE-dependent inflammation. PLoS ONE 5, e11944. doi:10.1371/journal.pone.0011944
62. Hua, X., Chason, K. D., Patel, J. Y., Naselsky, W C, and Tilley, S. L. (2011). IL-4 amplifies the pro-inflammatory effect of adenosine in human mast cells by changing expression levels of adenosine receptors. PLoS ONE 6, e24947. doi:10.1371/journal.pone.0024947
63. Hueber, A. J., Alves-Filho, J. C., Asquith, D. L., Michels, C., Millar, N. L., Reilly, J. H., Graham, G. J., Liew, E Y., Miller, A. M., and Mcinnes, I. B. (2011). IL-33 induces skin inflammation with mast cell and neutrophil activation. Eur. J. Immunol. 41, 2229-2237.
64. Hughes, P. J., Holgate, S. T., and Church, M. K. (1984). Adenosine inhibits and potentiates IgE-dependent histamine release from human lung mast cells by an A2-purinoceptor mediated mechanism. Biochem. Pharmacol. 33, 3847-3852.
65. Ilves, T., and Harvima, I. T. (2012). OX40 ligand and OX40 are increased in atopic dermatitis lesions but do not correlate with clinical severity. J. Eur. Acad. Derma-tol. Venereol. doi: 10.1111/j.1468-3083.2012.04587.x. [Epub ahead of print].
66. Isaksen, D. E., Baumann, H., Zhou, B., Nivollet, S., Farr, A. G., Levin, S. D., and Ziegler, S. R. (2002). Uncoupling of proliferation and Stat5 activation in thymic stromal lymphopoietin-mediated signal transduction. J. Immunol. 168, 3288-3294.
67. Ishimitsu, R., Nishimura, H., Yajima, T., Watase, T., Kawauchi, H., and Yoshikai, Y. (2001). Overexpression of IL-15 in vivo enhances Tc1 response, which inhibits allergic inflammation in a murine model of asthma. J. Immunol. 166, 1991-2001.
68. Ito, T., Wang, Y. H., Duramad, O., Hori, T., Delespesse, G. J., Watan-abe, N., Qin, E X., Yao, Z., Cao, W., and Liu, Y. J. (2005). TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand. J. Exp. Med. 202, 1213-1223.
69. IUPHAR Receptor Database. (2008). 5-Hydroxytryptamine receptors. International Union of Basic and Clinical Pharmacology. Available at: www.iuphar-db.org. [accessed April 11, 2008].
70. Jackson, N. E., Wang, H. W., Tedla, N., Mcneil, H. P., Geczy, C. L., Collins, A., Grimm, M. C., Hampartzoumian, T., and Hunt, J. E. (2005). IL-15 induces mast cell migration via a pertussis toxin-sensitive receptor. Eur. J. Immunol. 35, 2376-2385.
71. Jolly, P. S., Bektas, M., Olivera, A., Gonzalez-Espinosa, C., Proia, R. L., Rivera, J., Milstien, S., and Spiegel, S. (2004). Transactivation of sphingosine-1 -phosphate receptors by FcepsilonRI triggering is required for normal mast cell degranulation and chemotaxis. J. Exp. Med. 199, 959-970.
72. Jolly, P. S., Bektas, M., Watterson, K. R., Sankala, H., Payne, S. G., Milstien, S., and Spiegel, S. (2005). Expression of SphK1 impairs degranulation and motility of RBL-2H3 mast cells by desensitizing S1P receptors. Blood 105, 4736-4742.
73. Juremalm, M., and Nilsson, G. (2005). Chemokine receptor expression by mast cells. Chem. Immunol. Allergy 87, 130-144.
74. Juremalm, M., Olsson, N., and Nilsson, G. (2002). Selective CCL5/RANTES-induced mast cell migration through interactions with chemokine receptors CCR1 and CCR4. Biochem. Bio-phys. Res. Commun. 297, 480-485.
75. Kaplan, B. L., Lawver, J. E., Karmaus, P. W., Ngaotepprutaram, T., Birmingham, N. P., Harkema, J. R., and Kaminski, N. E. (2010). The effects of targeted deletion of cannabinoid receptors CB1andCB2on intranasal sensitization and challenge with adjuvant-free ovalbumin. Toxicol. Pathol. 38, 382-392.
76. Karni, A., Koldzic, D. N., Bharanidha-ran, P., Khoury, S. J., and Weiner, H. L. (2002). IL-18 is linked to raised IFN-gamma in multiple sclerosis and is induced by activated CD4(+) T cells via CD40-CD40 ligand interactions. J. Neuroimmunol. 125, 134-140.
77. Karra, L., Berent-Maoz, B., Ben-Zimra, M., and Levi-Schaffer, F. (2009). Are we ready to downregulate mast cells? Curr. Opin. Immunol. 21, 708-714.
78. Karra, L., and Levi-Schaffer, E (2011). Down-regulation of mast cell responses through ITIM containing inhibitory receptors. Adv. Exp. Med. Biol. 716, 143-159.
79. Kashiwakura, J., Yokoi, H., Saito, H., and Okayama, Y. (2004). T cell proliferation by direct cross-talk between OX40 ligand on human mast cells and OX40 on human T cells: comparison of gene expression profiles between human tonsillar and lung-cultured mast cells. J. Immunol. 173, 5247-5257.
80. Kataoka, T. R., Kumanogoh, A., Ban-dara, G., Metcalfe, D. D., and Gilfil-lan, A. M. (2010). CD72 negatively regulates KIT-mediated responses in human mast cells. J. Immunol. 184, 2468-2475.
81. Kim, E. J., Lee, S. M., Suk, K., and Lee, W. H. (2012). CD300a and CD300f differentially regulate the MyD88 and TRIF-mediated TLR signalling pathways through activation of SHP-1 and/or SHP-2 in human monocytic cell lines. Immunology 135, 226-235.
82. King, B. F., and Burnstock, G. (2002). "Purinergic receptors, "in Understanding G Protein-Coupled Receptors and Their Role in the CNS, eds M. Pangalos and C. Davies (Oxford, Oxford University Press), 422-438.
83. Knisz, J., Banks, A., Mckeag, L., Metcalfe, D. D., Rothman, P. B., and Brown, J. M. (2009). Loss of SOCS7 in mice results in severe cutaneous disease and increased mast cell activation. Clin. Immunol. 132, 277-284.
84. Konishi, H., Tsutsui, H., Murakami, T., Yumikura-Futatsugi, S., Yamanaka, K., Tanaka, M., Iwakura, Y., Suzuki, N., Takeda, K., Akira, S., Nakan-ishi, K., and Mizutani, H. (2002). IL-18 contributes to the spontaneous development of atopic dermatitis-like inflammatory skin lesion independently of IgE/stat6 under specific pathogen-free conditions. Proc. Natl. Acad. Sci. U.S.A. 99, 11340-11345.
85. Kumagai, H., Oki, T., Tamitsu, K., Feng, S. Z., Ono, M., Nakajima, H., Bao, Y. C., Kawakami, Y., Nagayoshi, K., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., Kawakami, T., and Kitamura, T. (2003). Identification and characterization of a new pair of immunoglobulin-like receptors LMIR1 and 2 derived from murine bone marrow-derived mast cells. Biochem. Biophys. Res. Commun. 307, 719-729.
86. Kunikata, T., Torigoe, K., Ushio, S., Okura, T., Ushio, C., Yamauchi, H., Ikeda, M., Ikegami, H., and Kurimoto, M. (1998). Constitutive and induced IL-18 receptor expression by various peripheral blood cell subsets as determined by anti-hIL-18R monoclonal antibody. Cell. Immunol. 189, 135-143.
87. Kushnir-Sukhov, N. M., Gilfillan, A. M., Coleman, J. W., Brown, J. M., Bruening, S., Toth, M., and Metcalfe, D. D. (2006). 5-hydroxytryptamine induces mast cell adhesion and migration. J. Immunol. 177, 6422-6432.
88. Lacotte, S., Brun, S., Muller, S., and Dumortier, H. (2009). CXCR3, inflammation, and autoimmune diseases. Ann. N. Y. Acad. Sci. 1173, 310-317.
89. Lankry, D., Simic, H., Klieger, Y., Levi-Schaffer, F., Jonjic, S., and Mandel-boim, O. (2010). Expression and function of CD300 in NK cells. J. Immunol. 185, 2877-2886.
90. Le, T. A., Takai, T., Vu, A. T., Kinoshita, H., Chen, X., Ikeda, S., Ogawa, H., and Okumura, K. (2011). Flagellin induces the expression of thymic stromal lymphopoietin in human keratinocytes via toll-like receptor 5. Int. Arch. Allergy Immunol. 155, 31-37.
91. Levi-Schaffer, F., and Eliashar, R. (2009). Mast cell stabilizing properties of antihistamines. J. Invest. Dermatol. 129, 2549-2551.
92. Liew, E Y., Pitman, N. I., and Mcinnes, I. B. (2010). Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat. Rev. Immunol. 10, 103-110.
93. Lippert, U., Artuc, M., Grutzkau, A., Babina, M., Guhl, S., Haase, I., Blaschke, V., Zachmann, K., Knosalla, M., Middel, P., Kruger-Krasagakis, S., and Henz, B. M. (2004). Human skin mast cells express H2 and H4, but not H3 receptors. J. Invest. Dermatol. 123, 116-123.
94. Liu, Y. J. (2007). Thymic stromal lymphopoietin and OX40 ligand pathway in the initiation of dendritic cell-mediated allergic inflammation. J. Allergy Clin. Immunol. 120, 238-244; quiz 245-236.
95. Lorenzen, I., Dingley, A. J., Jacques, Y., and Grotzinger, J. (2006). The structure of the interleukin-15 alpha receptor and its implications for ligand binding. J. Biol. Chem. 281, 6642-6647.
96. Luther, S. A., Bidgol, A., Hargreaves, D. C., Schmidt, A., Xu, Y., Paniyadi, J., Matloubian, M., and Cyster, J. G. (2002). Differing activities of home-ostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lym-phoid neogenesis. J. Immunol. 169, 424-433.
97. Malaviya, R., and Abraham, S. N. (2001). Mast cell modulation of immune responses to bacteria. Immunol. Rev. 179, 16-24.
98. Malaviya, R., Gao, Z., Thankavel, K., van der Merwe, P. A., and Abraham, S. N. (1999). The mast cell tumor necrosis factor alpha response to FimH-expressing Escherichia coli is mediated by the glycosylphosphatidylinositol-anchored molecule CD48. Proc. Natl. Acad. Sci. U.S.A. 96, 8110-8115.
99. Markovic, D., Punn, A., Lehnert, H., and Grammatopoulos, D. K. (2008). Intracellular mechanisms regulating corticotropin-releasing hormone receptor-2beta endocytosis and interaction with extracellularly regulated kinase 1/2 and p38 mitogen-activated protein kinase signaling cascades. Mol. Endocrinol. 22, 689-706.
100. Martinez-Barriocanal, A., Comas-Casellas, E., Schwartz, S. Jr., Martin, M., and Sayos, J. (2010). CD300 heterocomplexes, a new and family-restricted mechanism for myeloid cell signaling regulation. J. Biol. Chem. 285, 41781-41794.
101. Masini, E., Blandina, P., Brunelleschi, S., and Mannaioni, P. E (1982). Evidence for H2-receptor-mediated inhibition of histamine release from isolated rat mast cells. Agents Actions 12, 85-88.
102. Matsuda, H., Ptak, W., and Askenase, P. W. (1995). Role of mast cells versus basophils in IgE-dependent local ear skin release of the serotonin required to initiate contact sensitivity in mice. Int. Arch. Allergy Immunol. 107, 364.
103. McCurdy, J. D., Lin, T. J., and Marshall, J. S. (2001). Toll-like receptor 4-mediated activation of murine mast cells. J. Leukoc. Biol. 70, 977-984.
104. McCurdy, J. D., Olynych, T. J., Maher, L. H., and Marshall, J. S. (2003). Cutting edge: distinct Toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells. J. Immunol. 170, 1625-1629.
105. Meiser, A., Mueller, A., Wise, E. L., Mcdonagh, E. M., Petit, S. J., Saran, N., Clark, P. C., Williams, T. J., and Pease, J. E. (2008). The chemokine receptor CXCR3 is degraded following internalization and is replenished at the cell surface by de novo synthesis of receptor. J. Immunol. 180, 6713-6724.
106. Morse, K. L., Behan, J., Laz, T. M., West, R. E. Jr., Greenfeder, S. A., Anthes, J. C., Umland, S., Wan, Y., Hipkin, R. W., Gonsiorek, W., Shin, N., Gustafson, E. L., Qiao, X., Wang, S., Hedrick, J. A., Greene, J., Bayne, M., and Monsma, F. J. Jr. (2001). Cloning and characterization of a novel human histamine receptor. J. Pharmacol. Exp. Ther. 296, 1058-1066.
107. Mortier, E., Woo, T., Advincula, R., Gozalo, S., and Ma, A. (2008). IL-15Ralpha chaperones IL-15 to stable dendritic cell membrane complexes that activate NK cells via trans presentation. J. Exp. Med. 205, 1213-1225.
108. Munitz, A., Bachelet, I., Eliashar, R., Moretta, A., Moretta, L., and Levi-Schaffer, F. (2006a). The inhibitory receptor IRp60 (CD300a) suppresses the effects of IL-5, GM-CSF, and eotaxin on human peripheral blood eosinophils. Blood 107, 1996-2003.
109. Munitz, A., Bachelet, I., and Levi-Schaffer, F. (2006b). Reversal of airway inflammation and remodeling in asthma by a bispecific antibody fragment linking CCR3 to CD300a. J. Allergy Clin. Immunol. 118, 1082-1089.
110. Munitz, A., Bachelet, I., and Levi-Schaffer, F. (2007). CD48 as a novel target in asthma therapy. Recent Pat. Inflamm. Allergy Drug Discov. 1, 9-12.
111. Munoz, S., Hernandez-Pando, R., Abraham, S. N., and Enciso, J. A. (2003). Mast cell activation by Mycobacterium tuberculosis: mediator release and role of CD48. J. Immunol. 170, 5590-5596.
112. Nakahashi-Oda, C., Tahara-Hanaoka, S., Honda, S., Shibuya, K., and Shibuya, A. (2012). Identification of phosphatidylserine as a ligand for the CD300a immunoreceptor. Biochem. Biophys. Res. Commun. 417, 646-650.
113. Nakanishi, K., Yoshimoto, T., Tsut-sui, H., and Okamura, H. (2001). Interleukin-18 regulates both Th1 and Th2 responses. Annu. Rev. Immunol. 19, 423-474.
114. Nezi, M., Trianti-Dimoleni, V., and Mastorakos, G. (2010). "Corticotropin-releasing hormone (CRH) and the immune/inflammatory response, "in Adrenal Physiology and Diseases, Chap. 9, ed. G. Chrousos. Available at: www.endotext.org/adrenal/adrenal9
115. Nordlind, K., Azmitia, E. C., and Slominski, A. (2008). The skin as a mirror of the soul: exploring the possible roles of serotonin. Exp. Der-matol. 17, 301-311.
116. Novick, D., Kim, S. H., Fantuzzi, G., Reznikov, L. L., Dinarello, C. A., and Rubinstein, M. (1999). Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. Immunity 10, 127-136.
117. Nunomura, S., Gon, Y., Yoshimaru, T., Kashiwakura, J., Kawakami, T., and Ra, C. (2010). Fcep-silonRI beta-chain ITAM amplifies PI3K-signaling to ensure synergis-tic degranulation response via Fcep-silonRI and adenosine receptors. Eur. J. Immunol. 40, 1205-1217.
118. Ohkubo, T., Shibata, M., Inoue, M., Kaya, H., and Takahashi, H. (1994). Autoregulation of histamine release via the histamine H3 receptor on mast cells in the rat skin. Arch. Int. Pharmacodyn. Ther. 328, 307-314.
119. Ohta, Y., Hamada, Y., and Katsuoka, K. (2001). Expression of IL-18 in psoriasis. Arch. Dermatol. Res. 293, 334-342.
120. Okayama, Y., Okumura, S., Sagara, H., Yuki, K., Sasaki, T., Watan-abe, N., Fueki, M., Sugiyama, K., Takeda, K., Fukuda, T., Saito, H., and Ra, C. (2009). FcepsilonRI-mediated thymic stromal lymphopoietin production by interleukin-4-primed human mast cells. Eur. Respir. J. 34, 425-435.
121. Okayama, Y., Saito, H., and Ra, C. (2008). Targeting human mast cells expressing g-protein-coupled receptors in allergic diseases. Allergol. Int. 57, 197-203.
122. Olivera, A. (2008). Unraveling the complexities of sphingosine-1-phosphate function: the mast cell model. Prostaglandins Other Lipid Mediat. 86, 1-11.
123. Oliver-Vila, I., Saborit-Villarroya, I., Engel, P., and Martin, M. (2008). The leukocyte receptor CD84 inhibits Fc epsilon RI-mediated signaling through homophilic interaction in transfected RBL-2H3 cells. Mol. Immunol. 45, 2138-2149.
124. Olson, T. S., and Ley, K. (2002). Chemokines and chemokine receptors in leukocyte trafficking. Am. J. Physiol. Regul. Integr. Comp. Physiol. 283, R7-R28.
125. Omoto, Y., Tokime, K., Yamanaka, K., Habe, K., Morioka, T., Kurokawa, I., Tsutsui, H., Yamanishi, K., Nakanishi, K., and Mizutani, H. (2006). Human mast cell chy-mase cleaves pro-IL-18 and generates a novel and biologically active IL-18 fragment. J. Immunol. 177, 8315-8319.
126. Ono, E., Taniguchi, M., Higashi, N., Mita, H., Kajiwara, K., Yamaguchi, H., Tatsuno, S., Fukutomi, Y., Tan-imoto, H., Sekiya, K., Oshikata, C., Tsuburai, T., Tsurikisawa, N., Otomo, M., Maeda, Y., Hasegawa, M., Miyazaki, E., Kumamoto, T., and Akiyama, K. (2010). CD203c expression on human basophils is associated with asthma exacerbation. J. Allergy Clin. Immunol. 125, 483-489 e483.
127. Orinska, Z., Maurer, M., Mirghomizadeh, F., Bulanova, E., Metz, M., Nashkevich, N., Schie-mann, F., Schulmistrat, J., Budagian, V., Giron-Michel, J., Brandt, E., Paus, R., and Bulfone-Paus, S. (2007). IL-15 constrains mast cell-dependent antibacterial defenses by suppressing chymase activities. Nat. Med. 13, 927-934.
128. Oshikawa, K., Kuroiwa, K., Tago, K., Iwahana, H., Yanagisawa, K., Ohno, S., Tominaga, S. I., and Sugiyama, Y. (2001). Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation. Am. J. Respir. Crit. CareMed. 164, 277-281.
129. Oskeritzian, C. A., Price, M. M., Hait, N. C., Kapitonov, D., Falanga, Y. T., Morales, J. K., Ryan, J. J., Mil-stien, S., and Spiegel, S. (2010). Essential roles of sphingosine-1-phosphate receptor 2 in human mast cell activation, anaphylaxis, and pulmonary edema. J. Exp. Med. 207, 465-474.
130. Pacher, P., and Mechoulam, R. (2011). Is lipid signaling through cannabi-noid 2 receptors part of a protective system? Prog. LipidRes. 50, 193-211.
131. Park, L. S., Martin, U., Garka, K., Gliniak, B., di Santo, J. P., Muller, W., Largaespada, D. A., Copeland, N. G., Jenkins, N. A., Farr, A. G., Ziegler, S. E, Morrissey, P. J., Paxton, R., and Sims, J. E. (2000). Cloning of the murine thymic stromal lymphopoietin (TSLP) receptor: formation of a functional heteromeric complex requires interleukin 7 receptor. J. Exp. Med. 192, 659-670.
132. Paruchuri, S., Tashimo, H., Feng, C., Maekawa, A., Xing, W., Jiang, Y., Kanaoka, Y., Conley, P., and Boyce, J. A. (2009). Leukotriene E4-induced pulmonary inflammation is mediated by the P2Y12 receptor. J. Exp. Med. 206, 2543-2555.
133. Pegram, H. J., Andrews, D. M., Smyth, M. J., Darcy, P. K., and Kershaw, M. H. (2011). Activating and inhibitory receptors of natural killer cells. Immunol. Cell Biol. 89, 216-224.
134. Pertwee, R. G. (2006). The pharmacology of cannabinoid receptors and their ligands: an overview. Int. J. Obes. (Lond.) 30(Suppl. 1), S13-S18.
135. Pietrzak, A., Wierzbicki, M., Wiktorska, M., and Brzezinska-Blaszczyk, E. (2011). Surface TLR2 and TLR4 expression on mature rat mast cells can be affected by some bacterial components and proinflammatory cytokines. Mediators Inflamm. 2011, 427-473.
136. Pillot, C., Heron, A., Cochois, V., Tardivel-Lacombe, J., Ligneau, X., Schwartz, J. C., and Arrang, J. M. (2002). A detailed mapping of the histamine H(3) receptor and its gene transcripts in rat brain. Neuroscience 114, 173-193.
137. Pini, A., Mannaioni, G., Pellegrini-Giampietro, D., Passani, M. B., Mas-troianni, R., Bani, D., and Masini, E. (2012). The role of cannabinoids in inflammatory modulation of allergic respiratory disorders, inflammatory pain and ischemic stroke. Curr. DrugTargets 13, 984-993.
138. Plater-Zyberk, C., Joosten, L. A., Helsen, M. M., Sattonnet-Roche, P., Siegfried, C., Alouani, S., van de Loo, F. A., Graber, P., Aloni, S., Cirillo, R., Lubberts, E., Dinarello, C. A., van den Berg, W. B., and Chvatchko, Y. (2001). Therapeutic effect of neutralizing endogenous IL-18 activity in the collagen-induced model of arthritis. J. Clin. Invest. 108, 1825-1832.
139. Price, M. M., Kapitonov, D., Allegood, J., Milstien, S., Oskeritzian, C. A., and Spiegel, S. (2009). Sphingosine-1-phosphate induces development of functionally mature chymase-expressing human mast cells from hematopoietic progenitors. FASEBJ. 23, 3506-3515.
140. Proft, T., and Baker, E. N. (2009). Pili in Gram-negative and Gram-positive bacteria - structure, assembly and their role in disease. Cell. Mol. Life Sci. 66, 613-635.
141. Ritter, M., El-Nour, H., Hedblad, M. A., Butterfield, J. H., Beck, O., Stephan-son, N., Holst, M., Giscombe, R., Azmitia, E. C., and Nordlind, K. (2012). Serotonin and its 5-HT1 receptor in human mastocytosis. Immunopharmacol. Immunotoxicol. 34, 679-685.
142. Rocha-de-Souza, C. M., Berent-Maoz, B., Mankuta, D., Moses, A. E., andLevi-Schaffer, F. (2008). Human mast cell activation by Staphylococ-cus aureus: interleukin-8 and tumor necrosis factor alpha release and the role of Toll-like receptor 2 and CD48 molecules. Infect. Immun. 76, 4489-4497.
143. Rochman, Y., and Leonard, W. J. (2008). Thymic stromal lymphopoietin: a new cytokine in asthma. Curr. Opin. Pharmacol. 8, 249-254.
144. Rosethorne, E. M., and Charlton, S. J. (2011). Agonist-biased signaling at the histamine H4 receptor: JNJ7777120 recruits beta-arrestin without activating G proteins. Mol. Pharmacol. 79, 749-757.
145. Rozniecki, J. J., Letourneau, R., Sug-iultzoglu, M., Spanos, C., Gorbach, J., and Theoharides, T. C. (1999). Differential effect of histamine 3 receptor-active agents on brain, but not peritoneal, mast cell activation. J. Pharmacol. Exp. Ther. 290, 1427-1435.
146. Sabato, V., Verweij, M. M., Bridts, C. H., Levi-Schaffer, F., Gibbs, B. E, de Clerck, L. S., Schiavino, D., and Ebo, D. G. (2012). CD300a is expressed on human basophils and seems to inhibit IgE/FcepsilonRI-dependent anaphylactic degranula-tion. Cytometry B Clin. Cytom. 82, 132-138.
147. Sanchez, T., Skoura, A., Wu, M. T., Casserly, B., Harrington, E. O., and Hla, T. (2007). Induction of vascular permeability by the sphingosine-1-phosphate receptor-2 (S1P2R) and its downstream effectors ROCK and PTEN. Arterioscler. Thromb. Vasc. Biol. 27, 1312-1318.
148. Shikotra, A., Choy, D. F., Ohri, C. M., Doran, E., Butler, C., Har-gadon, B., Shelley, M., Abbas, A. R., Austin, C. D., Jackman, J., Wu, L. C., Heaney, L. G., Arron, J. R., and Bradding, P. (2012). Increased expression of immunore-active thymic stromal lymphopoietin in patients with severe asthma. J. Allergy Clin. Immunol. 129, 104-111 e101-109.
149. Shin, J. S., and Abraham, S. N. (2001). Glycosylphosphatidylinositol-anchored receptor-mediated bacterial endocytosis. FEMS Microbiol. Lett. 197, 131-138.
150. Silver, M. R., Margulis, A., Wood, N., Goldman, S. J., Kasaian, M., and Chaudhary, D. (2010). IL-33 synergizes with IgE-dependent and IgE-independent agents to promote mast cell and basophil activation. Inflamm. Res. 59, 207-218.
151. Simhadri, V. R., Andersen, J. F., Calvo, E., Choi, S. C., Coligan, J. E., and Borrego, E (2012). Human CD300a binds to phosphatidylethanolamine and phosphatidylserine, and modulates the phagocytosis of dead cells. Blood 119, 2799-2809.
152. Slominski, A., Wortsman, J., Pisarchik, A., Zbytek, B., Linton, E. A., Mazurkiewicz, J. E., and Wei, E. T. (2001). Cutaneous expression of corticotropin-releasing hormone (CRH), urocortin, and CRH receptors. FASEBJ. 15, 1678-1693.
153. Smrz, D., Iwaki, S., Mcvicar, D. W., Metcalfe, D. D., and Gilfillan, A. M. (2010). TLR-mediated signaling pathways circumvent the requirement for DAP12 in mast cells for the induction of inflammatory mediator release. Eur. J. Immunol. 40, 3557-3569.
154. Spiegel, S., and Milstien, S. (2011). The outs and the ins of sphingosine-1-phosphate in immunity. Nat. Rev. Immunol. 11, 403-415.
155. Steiner, M. A., and Wotjak, C. T. (2008). Role of the endocannabinoid system in regulation of the hypothalamic-pituitary-adrenocortical axis. Prog. Brain Res. 170, 397-432.
156. Sugawara, K., Biro, T., Tsuruta, D., Toth, B. I., Kromminga, A., Zakany, N., Zimmer, A., Funk, W., Gibbs, B. F., Zimmer, A., and Paus, R. (2012). Endocannabinoids limit excessive mast cell maturation and activation in human skin. J. Allergy Clin. Immunol. 129, 726-738.
157. Supajatura, V., Ushio, H., Nakao, A., Akira, S., Okumura, K., Ra, C., and Ogawa, H. (2002). Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity. J. Clin. Invest. 109, 1351-1359.
158. Tajima, S., Oshikawa, K., Tominaga, S., and Sugiyama, Y. (2003). The increase in serum soluble ST2 protein upon acute exacerbation of idiopathic pulmonary fibrosis. Chest 124, 1206-1214.
159. Takai, T. (2012). TSLP expression: cellular sources, triggers, and regulatory mechanisms. Allergol. Int. 61, 3-17.
160. Takeshita, K., Sakai, K., Bacon, K. B., and Gantner, E (2003). Critical role of histamine H4 receptor in leukotriene B4 production and mast cell-dependent neutrophil recruitment induced by zymosan in vivo. J. Pharmacol. Exp. Ther. 307, 1072-1078.
161. Tateno, H., Crocker, P. R., and Paulson, J. C. (2005). Mouse Siglec-F and human Siglec-8 are functionally convergent paralogs that are selectively expressed on eosinophils and recognize 6'-sulfo-sialyl Lewis X as a preferred glycan ligand. Glycobiology 15, 1125-1135.
162. Taylor, B. C., Zaph, C., Troy, A. E., Du, Y., Guild, K. J., Comeau, M. R., and Artis, D. (2009). TSLP regulates intestinal immunity and inflammation in mouse models of helminth infection and colitis. J. Exp. Med. 206, 655-667.
163. Theoharides, T. C., Singh, L. K., Boucher, W., Pang, X., Letourneau, R., Webster, E., and Chrousos, G. (1998). Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects. Endocrinology 139, 403-413.
164. Thomassen, E., Bird, T. A., Renshaw, B. R., Kennedy, M. K., and Sims, J. E. (1998). Binding of interleukin-18 to the interleukin-1 receptor homologous receptor IL-1Rrp1 leads to activation of signaling pathways similar to those used by interleukin-1. J. Interferon Cytokine Res. 18, 1077-1088.
165. Tilly, B. C., Tertoolen, L. G., Remorie, R., Ladoux, A., Verlaan, I., de Laat, S. W., and Moolenaar, W. H. (1990). Histamine as a growth factor and chemoattractant for human carcinoma and melanoma cells: action through Ca2(+)-mobilizing H1 receptors. J. Cell Biol. 110, 1211-1215.
166. Van Kolen, K., and Slegers, H. (2006). Integration of P2Y receptor-activated signal transduction pathways in G protein-dependent signalling networks. Purinergic Signal. 2, 451-469.
167. Vieira, R. P., Muller, T., Grimm, M., Von Gernler, V., Vetter, B., Durk, T., Cicko, S., Ayata, C. K., Sorichter, S., Robaye, B., Zeiser, R., Ferrari, D., Kirschbaum, A., Zissel, G., Virchow, J. C., Boeynaems, J. M., and Idzko, M. (2011). Purinergic receptor type 6 contributes to airway inflammation and remo deling in experimental allergic airway inflammation. Am. J. Respir. Crit. CareMed. 184, 215-223.
168. Villadsen, L. S., Schuurman, J., Beurskens, F., Dam, T. N., Dagnaes-Hansen, F., Skov, L., Rygaard, J., Voorhorst-Ogink, M. M., Gerritsen, A. F., Van Dijk, M. A., Parren, P. W., Baadsgaard, O., and van de Winkel, J. G. (2003). Resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse model. J. Clin. Invest. 112, 1571-1580.
169. Waldmann, T. A. (2004). Targeting the inter leukin-15/interleukin-15 receptor system in inflammatory autoimmune diseases. Arthritis Res. Ther. 6, 174-177.
170. Waldmann, T. A. (2006). The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. Nat. Rev. Immunol. 6, 595-601.
171. Wang, L., Gantz, I., and Delvalle, J. (1996). Histamine H2 receptor activates adenylate cyclase and PLC via separate GTP-dependent pathways. Am. J. Physiol. 271, G613-G620.
172. Wang, Y. H., and Liu, Y. J. (2007). OX40-OX40L interactions: a promising therapeutic target for allergic diseases?J. Clin. Invest. 117, 3655-3657.
173. Wang, Z., Lai, Y., Bernard, J. J., Macleod, D. T., Cogen, A. L., Moss, B., and Di Nardo, A. (2012). Skin mast cells protect mice against vaccinia virus by triggering mast cell receptor S1PR2 and releasing antimicrobial peptides.J. Immunol. 188, 345-357.
174. Wiener, Z., Pocza, P., Racz, M., Nagy, G., Tolgyesi, G., Molnar, V, Laeger, J., Buzas, E., Gorbe, E., Papp, Z., Rigo, J., and Falus, A. (2008). IL-18 induces a marked gene expression profile changeandincreasedCcl1 (I-309) production in mouse mucosal mast cell homologs. Int. Immunol. 20, 1565-1573.
175. Willox, I., Mirkina, I., Westwick, J., and Ward, S. G. (2010). Evidence for PI3K-dependent CXCR3 agonist-induced degranulation of human cord blood-derived mast cells. Mol. Immunol. 47, 2367-2377.
176. Woolley, D. E., and Tetlow, L. C. (2000). Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion. Arthritis Res. 2, 65-74.
177. Wu, H. J., and Bondada, S. (2009). CD72, a coreceptor with both positive and negative effects on B lymphocyte development and function. J. Clin. Immunol. 29, 12-21.
178. Xu, D., Jiang, H. R., Kewin, P., Li, Y., Mu, R., Fraser, A. R., Pitman, N., Kurowska-Stolarska, M., Mckenzie, A. N., Mcinnes, I. B., and Liew, E Y (2008). IL-33 exacerbates antigen-induced arthritis by activating mast cells. Proc. Natl.Acad. Sci. U.S.A. 105, 10913-10918.
179. Ying, S., O'Connor, B., Ratoff, J., Meng, Q., Fang, C., Cousins, D., Zhang, G., Gu, S., Gao, Z., Shamji, B., Edwards, M. J., Lee, T. H., and Corrigan, C. J. (2008). Expression and cellular provenance of thymic stromal lymphopoietin and chemokines in patients with severe asthma and chronic obstructive pulmonary disease. J. Immunol. 181, 2790-2798.
180. Ying, S., O'Connor, B., Ratoff, J., Meng, Q., Mallett, K., Cousins, D., Robinson, D., Zhang, G., Zhao, J., Lee, T. H., and Corrigan, C. (2005). Thymic stromal lymphopoietin expression is increased in asthmatic airways and correlates with expression of Th2-attracting chemokines and disease severity. J. Immunol. 174, 8183-8190.
181. Yip, K. H., Wong, L. L., and Lau, H. Y. (2009). Adenosine: roles of different receptor subtypes in mediating histamine release from human and rodent mast cells. Inflamm. Res. 58(Suppl. 1), 17-19.
182. Yokoi, H., Choi, O. H., Hubbard, W., Lee, H. S., Canning, B. J., Lee, H. H., Ryu, S. D., Von Gunten, S., Bickel, C. A., Hudson, S. A., Macglashan, D. W. Jr., and Bochner, B. S. (2008). Inhibition of FcepsilonRI-dependent mediator release and calcium flux from human mast cells by sialic acid-binding immunoglobulin-like lectin 8 engagement. J. Allergy Clin. Immunol. 121, 499-505 e491.
183. Yoo, J., Omori, M., Gyarmati, D., Zhou, B., Aye, T., Brewer, A., Comeau, M. R., Campbell, D. J., and Ziegler, S. E (2005). Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin. J. Exp. Med. 202, 541-549.
184. Young, M.R., and Matthews, J. P. (1995). Serotonin regulation of T-cell sub-populations and of macrophage accessory function. Immunology 84, 148-152.
185. Yu, S., Stahl, E., Li, Q., and Ouyang, A. (2008). Antigen inhalation induces mast cells and eosinophils infiltration in the guinea pig esophageal epithelium involving histamine-mediated pathway. Life Sci. 82, 324-330.
186. Zhang, F., Huang, G., Hu, B., Song, Y., and Shi, Y (2011). A soluble thymic stromal lymphopoietin (TSLP) antagonist, TSLPR-immunoglobulin, reduces the severity of allergic disease by regulating pulmonary dendritic cells. Clin. Exp. Immunol. 164, 256-264.
187. Zhu, Y., Michalovich, D., Wu, H., Tan, K. B., Dytko, G. M., Mannan, I. J., Boyce, R., Alston, J., Tierney, L. A., Li, X., Herrity, N. C., Vawter, L., Sarau, H. M., Ames, R. S., Davenport, C. M., Hieble, J. P., Wilson, S., Bergsma, D. J., and Fitzgerald, L. R. (2001). Cloning, expression, and pharmacological characterization of a novel human histamine receptor. Mol. Pharmacol. 59, 434-441.
188. Ziegler, S. F., and Artis, D. (2010). Sensing the outside world: TSLP regulates barrier immunity. Nat. Immunol. 11, 289-293.
189. Zimmermann, N., King, N. E., Laporte, J., Yang, M., Mishra, A., Pope, S. M., Muntel, E. E., Witte, D. P., Pegg, A. A., Foster, P. S., Hamid, Q., and Rothenberg, M. E. (2003). Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis. J. Clin. Invest. 111, 1863-1874.